Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Plx Pharma Inc (PLXP)

Plx Pharma Inc (PLXP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 525,968
  • Shares Outstanding, K 26,890
  • Annual Sales, $ 30 K
  • Annual Income, $ -15,210 K
  • 60-Month Beta 5.11
  • Price/Sales 16,922.77
  • Price/Cash Flow N/A
  • Price/Book 10.58
Trade PLXP with:

Options Overview Details

View History
  • Implied Volatility 92.75%
  • Historical Volatility 50.51%
  • IV Percentile 43%
  • IV Rank 24.61%
  • IV High 170.16% on 03/31/21
  • IV Low 67.48% on 05/28/21
  • Put/Call Vol Ratio 0.57
  • Today's Volume 948
  • Volume Avg (30-Day) 648
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 6,094
  • Open Int (30-Day) 5,007

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.47
  • Number of Estimates 2
  • High Estimate -0.44
  • Low Estimate -0.49
  • Prior Year -0.40
  • Growth Rate Est. (year over year) -17.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.02 +24.72%
on 09/20/21
19.98 unch
on 09/24/21
+2.63 (+15.16%)
since 08/24/21
3-Month
11.58 +72.54%
on 07/08/21
21.50 -7.07%
on 07/22/21
+5.79 (+40.80%)
since 06/24/21
52-Week
3.00 +566.00%
on 11/02/20
21.50 -7.07%
on 07/22/21
+16.73 (+514.77%)
since 09/24/20

Most Recent Stories

More News
PLx Pharma Inc. to Present at Upcoming Virtual Healthcare Industry Conferences

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard(TM) drug delivery platform to provide more...

PLXP : 19.98 (+2.15%)
PLx Pharma Inc.'s VAZALORE(TM) Now on Shelves; National Media Campaign Launches Today

-- Executing broad reach television advertising to support the launch of VAZALORE --

PLXP : 19.98 (+2.15%)
PLx Pharma Inc. Reports Second Quarter 2021 Results and Provides Business Update

--Walmart, Walgreens, Rite Aid, CVS and many other retailers placing VAZALORE on shelves later this month--

PLXP : 19.98 (+2.15%)
PLx Pharma Inc.'s VAZALORE to Launch in Nearly 8,000 CVS Stores this Month

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard(TM) drug delivery platform to provide more...

PLXP : 19.98 (+2.15%)
PLx Pharma Inc.'s VAZALORE to Launch in Over 2,400 Rite Aid Stores in August

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard(TM) drug delivery platform to provide more...

RAD : 14.20 (-0.21%)
PLXP : 19.98 (+2.15%)
PLx Pharma Inc. to Discuss 2021 Second Quarter Financial Results on August 6, 2021 Conference Call and Provide Business Update

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard(TM) drug delivery platform to provide more...

PLXP : 19.98 (+2.15%)
PLx Pharma Inc.'s VAZALORE to Launch in over 8,000 Walgreens Stores Nationwide in August

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard(TM) drug delivery platform to provide more...

PLXP : 19.98 (+2.15%)
PLx Pharma Inc.'s VAZALORE to Launch in over 4,500 Walmart Stores Nationwide in August

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard(TM) drug delivery platform to provide more...

PLXP : 19.98 (+2.15%)
PLx Pharma Inc. to Present at Upcoming Healthcare Industry Conferences

PLx Pharma Inc. (NASDAQ: PLXP) ("PLx" or the "Company"), a specialty pharmaceutical company focused on its clinically-validated and patent-protected PLxGuard(TM) drug delivery platform to provide more...

PLXP : 19.98 (+2.15%)
Thinking about buying stock in Scopus Biopharma, Verastem, Vistagen, PLx Pharma, or Commercial Vehicle?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SCPS, VSTM, VTGN, PLXP, and CVGI.

CVGI : 9.79 (+3.38%)
SCPS : 4.36 (+2.35%)
VSTM : 3.06 (-4.38%)
PLXP : 19.98 (+2.15%)
VTGN : 2.93 (-0.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

PLx Pharma Inc. is a specialty pharmaceutical company. It focused on developing clinically validated and patent-protected PLxGuard(TM) delivery system to provide safe and effective aspirin products. PLx Pharma Inc., formerly known as Dipexium Pharmaceuticals Inc., is based in NEW YORK, United States....

See More

Key Turning Points

3rd Resistance Point 21.09
2nd Resistance Point 20.52
1st Resistance Point 20.04
Last Price 19.98
1st Support Level 18.99
2nd Support Level 18.42
3rd Support Level 17.94

See More

52-Week High 21.50
Last Price 19.98
Fibonacci 61.8% 14.43
Fibonacci 50% 12.25
Fibonacci 38.2% 10.07
52-Week Low 3.00

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar